Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies.
Rice A, Verma M, Voigt E, Battisti P, Beaver S, Reed S, Dinkins K, Mody S, Zakin L, Tanaka S, Morimoto B, Olson CA, Gabitzsch E, Safrit JT, Spilman P, Casper C, Soon-Shiong P.
Rice A, et al.
Front Immunol. 2022 Jul 15;13:910136. doi: 10.3389/fimmu.2022.910136. eCollection 2022.
Front Immunol. 2022.
PMID: 35911728
Free PMC article.